세계의 환자 안전 및 위험 소프트웨어 시장 : 기능별, 전개 모드별, 최종사용자별, 지역별 - 예측(-2030년)

The global patient safety and risk software market is projected to reach USD 2.99 billion by 2030 from USD 1.75 billion in 2025, at a high CAGR of 11.36% during the forecast period. The patient safety and risk software market is emerging as a critical priority for healthcare systems worldwide, aimed at minimizing medical errors and improving the quality of care. Its growth is being driven by rising incidences of adverse events, increasing complexity of healthcare delivery, and the push toward value-based care models.

Regulatory frameworks from bodies such as the FDA, EMA, and The Joint Commission mandate strict reporting, monitoring, and compliance, compelling providers and life sciences companies to adopt advanced PSRM solutions. At the same time, government initiatives, such as the US Department of Health and Human Services' patient safety programs and the EU's pharmacovigilance regulations, are accelerating adoption. However, barriers such as high implementation costs, lack of global standardization, integration challenges with legacy systems, and underreporting of safety events continue to limit widespread adoption.

Compliance & governance under the function segment is expected to register the fastest growth during the forecast period.

The compliance & governance segment is the fastest-growing segment during the forecast period, driven by the rising emphasis on meeting regulatory requirements and maintaining transparency in healthcare operations. Increasing scrutiny from regulatory bodies, coupled with the need for standardized reporting and audit trails, is encouraging healthcare organizations to adopt advanced compliance management solutions. These tools help ensure adherence to quality standards, data protection regulations, and patient safety protocols, thereby supporting risk mitigation and operational efficiency across the healthcare ecosystem.

The cloud-based deployment segment is projected to register the fastest growth during the forecast period.

The cloud-based segment is the fastest-growing segment, driven by the rising adoption of digital health technologies and the shift toward flexible, scalable deployment models. Cloud solutions offer seamless data access, interoperability, and real-time collaboration across healthcare settings, enabling faster decision-making and improved patient safety outcomes. Additionally, lower upfront costs, reduced IT infrastructure requirements, and enhanced data security through advanced encryption and compliance measures are further accelerating the adoption of cloud-based platforms in this market.

Asia Pacific is expected to witness the highest growth rate during the forecast period.

The Asia Pacific region is positioned to register the highest CAGR in the patient safety and risk software market, driven by unprecedented healthcare digitization, government initiatives, and substantial technology investments. For example, the smart hospital program in China aims to upgrade over 1,000 public hospitals by 2025 with integrated IT solutions. The growing burden of medical errors, expansion of healthcare infrastructure, and the push for EHR/EMR integration across emerging economies such as India, China, and Southeast Asia are further fueling adoption. The expanding pharmaceutical and medical device sectors in the region, coupled with a rising patient population, are creating strong demand for efficient risk management and safety solutions.

In-depth interviews have been conducted with chief executive officers (CEOs), Directors, and other executives from various key organizations operating in the authentication and brand protection marketplace. The breakdown of primary participants is as mentioned below:

• By Company Type - Tier 1: 31%, Tier 2: 28%, and Tier 3: 41%
• By Designation - C Level: 31%, Director Level: 25%, and Others: 44%
• By Region - North America: 32%, Europe: 32%, Asia Pacific: 26%, Middle East & Africa: 5%, Latin America: 5%

Key Players

The key players operating in the patient safety and risk software market include Riskonnect, Inc. (US), Origami Risk LLC (US), RLDatix (US), Health Catalyst (US), symplr (US), Clarity Group, Inc. (US), Performance Health Partners (US), MorCare, LLC (US), RiskQual Technologies, Inc. (US), Prista Corporation (US), IQVIA Inc. (US), Inovalon (US), NAVEX Global, Inc. (US), Censinet (US), American Data Network (US), Arventa Pty Ltd (Australia), ComplianceQuest (US), Radar Healthcare Inc (UK), Pascal Metrics Inc. (US), and SafeQual Health (US)

Research Coverage

The report analyzes the patient safety and risk software market and estimate the market size and future growth potential of various market segments, based on function, deployment mode, end user, and region. The report also provides a competitive analysis of the key players operating in this market, along with their company profiles, product offerings, recent developments, and key market strategies.

Reasons to Buy the Report

This report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them garner a higher share of the market. Firms purchasing the report could use one or a combination of the following strategies to strengthen their positions in the market.

This report provides insights into:

• Analysis of key drivers (rising patient safety incidents, increasing prioritization of patient safety, escalating healthcare costs and shift toward value-based care models, increasing adoption of digital health technologies), restraints (high implementation and maintenance costs, resistance to adoption and perceived complexity of patient safety and risk software, data privacy and interoperability challenges), opportunities (growing adoption of AI, predictive analytics, and automation, increasing adoption of patient safety and risk software into MedTech and pharma safety domains, integration of patient safety and risk software with population health and real-world evidence platforms), challenges (lack of global standardization in safety reporting, complex integration with legacy systems, limited awareness and underreporting of safety incidents)
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and solution launches in the patient safety and risk software market.
• Market Development: Comprehensive information on the lucrative emerging markets, function, deployment mode, end user, and region
• Market Diversification: Exhaustive information about the product portfolios, growing geographies, recent developments, and investments in the patient safety and risk software market
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, and capabilities of the leading players in the patient safety & risk software market such as Riskonnect, Inc. (US), Origami Risk LLC (US), RLDatix (US), symplr (US), and Radar Healthcare Inc (UK)

TABLE OF CONTENTS

1 INTRODUCTION

• 1.1 STUDY OBJECTIVES
• 1.2 MARKET DEFINITION
• 1.3 STUDY SCOPE
  • 1.3.1 MARKETS COVERED AND REGIONAL SCOPE
  • 1.3.2 INCLUSIONS AND EXCLUSIONS
  • 1.3.3 YEARS CONSIDERED
• 1.4 CURRENCY CONSIDERED
• 1.5 STAKEHOLDERS

2 RESEARCH METHODOLOGY

• 2.1 RESEARCH DATA
  • 2.1.1 SECONDARY DATA
    • 2.1.1.1 Key data from secondary sources
  • 2.1.2 PRIMARY DATA
    • 2.1.2.1 Key data from primary sources
    • 2.1.2.2 Insights from primary experts
• 2.2 MARKET SIZE ESTIMATION
• 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
• 2.4 RESEARCH ASSUMPTIONS
  • 2.4.1 MARKET SIZING ASSUMPTIONS
  • 2.4.2 OVERALL STUDY ASSUMPTIONS
• 2.5 RESEARCH LIMITATIONS
  • 2.5.1 METHODOLOGY-RELATED LIMITATIONS
  • 2.5.2 SCOPE-RELATED LIMITATIONS
• 2.6 RISK ANALYSIS

3 EXECUTIVE SUMMARY

4 PREMIUM INSIGHTS

• 4.1 PATIENT SAFETY AND RISK SOFTWARE MARKET OVERVIEW
• 4.2 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER AND REGION
• 4.3 PATIENT SAFETY AND RISK SOFTWARE MARKET: GEOGRAPHIC SNAPSHOT
• 4.4 PATIENT SAFETY AND RISK SOFTWARE MARKET: DEVELOPED MARKETS VS. EMERGING MARKETS

5 MARKET OVERVIEW

• 5.1 INTRODUCTION
• 5.2 MARKET DYNAMICS
  • 5.2.1 DRIVERS
    • 5.2.1.1 Rising patient safety incidents
    • 5.2.1.2 Increasing prioritization of patient safety
    • 5.2.1.3 Escalating healthcare costs and shift toward value-based care models
    • 5.2.1.4 Increasing adoption of digital health technologies
  • 5.2.2 RESTRAINTS
    • 5.2.2.1 High implementation and maintenance costs
    • 5.2.2.2 Resistance to adoption and perceived complexity of patient safety and risk software
    • 5.2.2.3 Data privacy and interoperability challenges
  • 5.2.3 OPPORTUNITIES
    • 5.2.3.1 Growing adoption of AI, predictive analytics, and automation
    • 5.2.3.2 Increasing adoption of patient safety and risk solutions into MedTech and pharma safety domains
    • 5.2.3.3 Integration of patient safety and risk software with population health and real-world evidence platforms
  • 5.2.4 CHALLENGES
    • 5.2.4.1 Lack of global standardization in safety reporting
    • 5.2.4.2 Complex integration with legacy systems
    • 5.2.4.3 Limited awareness and underreporting of safety events
• 5.3 INDUSTRY TRENDS
  • 5.3.1 MOBILE HEALTH PLATFORMS
  • 5.3.2 CLOUD-BASED ALARM MANAGEMENT SOLUTION
  • 5.3.3 IOT-ENABLED SOLUTIONS
• 5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESS
• 5.5 PRICING ANALYSIS
  • 5.5.1 INDICATIVE PRICING ANALYSIS, BY KEY PLAYER
  • 5.5.2 INDICATIVE PRICING ANALYSIS, BY REGION
• 5.6 VALUE CHAIN ANALYSIS
• 5.7 ECOSYSTEM ANALYSIS
• 5.8 INVESTMENT AND FUNDING SCENARIO
• 5.9 TECHNOLOGY ANALYSIS
  • 5.9.1 KEY TECHNOLOGIES
    • 5.9.1.1 AI-powered risk scoring
    • 5.9.1.2 Automated root cause analysis
    • 5.9.1.3 Real-time safety dashboards
    • 5.9.1.4 Mobile incident reporting apps
  • 5.9.2 ADJACENT TECHNOLOGIES
    • 5.9.2.1 Cloud SaaS platforms
    • 5.9.2.2 Blockchain
  • 5.9.3 COMPLEMENTARY TECHNOLOGIES
    • 5.9.3.1 EHR/EMR integration
    • 5.9.3.2 Claims and billing systems
    • 5.9.3.3 Credentialing systems
• 5.10 PATENT ANALYSIS
  • 5.10.1 PATENT PUBLICATION TREND
  • 5.10.2 LIST OF PATENTS
• 5.11 KEY CONFERENCES AND EVENTS, 2025-2027
• 5.12 CASE STUDY ANALYSIS
  • 5.12.1 ADOPTION OF VIRTUAL OBSERVATION SOLUTION TO REDUCE FALL RATES IN PATIENTS
  • 5.12.2 UTILIZATION OF ENTERPRISE RISK MANAGEMENT SYSTEM FOR ENHANCED PATIENT SAFETY
  • 5.12.3 USE OF COMPREHENSIVE HEALTHCARE RISK MANAGEMENT SOFTWARE FOR IMPROVED REGULATORY COMPLIANCE
• 5.13 REGULATORY LANDSCAPE
  • 5.13.1 REGULATORY ANALYSIS
  • 5.13.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
• 5.14 PORTER'S FIVE FORCES ANALYSIS
  • 5.14.1 BARGAINING POWER OF SUPPLIERS
  • 5.14.2 BARGAINING POWER OF BUYERS
  • 5.14.3 THREAT OF NEW ENTRANTS
  • 5.14.4 THREAT OF SUBSTITUTES
  • 5.14.5 INTENSITY OF COMPETITIVE RIVALRY
• 5.15 KEY STAKEHOLDERS AND BUYING CRITERIA
  • 5.15.1 KEY STAKEHOLDERS IN BUYING PROCESS
  • 5.15.2 BUYING CRITERIA
• 5.16 END-USER ANALYSIS
  • 5.16.1 UNMET NEEDS
  • 5.16.2 END-USER EXPECTATIONS
• 5.17 BUSINESS MODEL
  • 5.17.1 SUBSCRIPTION LICENSING
  • 5.17.2 MODULAR PLATFORM APPROACH
  • 5.17.3 IMPLEMENTATION AND INTEGRATION FEES
  • 5.17.4 VALUE-ADDED SERVICES
  • 5.17.5 MARKETPLACE INTEGRATION AND REGIONAL PRICING
• 5.18 IMPACT OF AI/GEN AI ON PATIENT SAFETY AND RISK SOFTWARE MARKET
  • 5.18.1 INTRODUCTION
  • 5.18.2 TOP USE CASES AND MARKET POTENTIAL
  • 5.18.3 KEY USE CASES
  • 5.18.4 CASE STUDY ON AI/GENERATIVE AI IMPLEMENTATION
    • 5.18.4.1 Use of AI-powered data extraction platform with risk management software
  • 5.18.5 INTERCONNECTED AND ADJACENT ECOSYSTEMS
    • 5.18.5.1 Pharmacovigilance and drug safety monitoring
    • 5.18.5.2 Healthcare information exchange
    • 5.18.5.3 Quality improvement software
    • 5.18.5.4 Healthcare GRC
  • 5.18.6 USER READINESS AND IMPACT ASSESSMENT
    • 5.18.6.1 Healthcare providers
    • 5.18.6.2 Pharmaceutical & biotechnology companies
• 5.19 IMPACT OF 2025 US TARIFF
  • 5.19.1 INTRODUCTION
  • 5.19.2 KEY TARIFF RATES
  • 5.19.3 PRICE IMPACT ANALYSIS
  • 5.19.4 IMPACT ON COUNTRY/REGION
    • 5.19.4.1 US
    • 5.19.4.2 Europe
    • 5.19.4.3 Asia Pacific
  • 5.19.5 IMPACT ON END-USE INDUSTRIES

6 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY FUNCTION

• 6.1 INTRODUCTION
• 6.2 RISK & SAFETY MANAGEMENT
  • 6.2.1 INCIDENT REPORTING SYSTEMS
    • 6.2.1.1 Need for real-time reporting and automated workflows to support growth
  • 6.2.2 EVENT MANAGEMENT & ROOT CAUSE ANALYSIS SOFTWARE
    • 6.2.2.1 Ability to analyze incident patterns and implement risk mitigation to promote growth
  • 6.2.3 PATIENT LEARNING SYSTEMS
    • 6.2.3.1 Increasing focus on improving patient safety to foster growth
• 6.3 COMPLIANCE & GOVERNANCE
  • 6.3.1 RISK/COMPLIANCE MONITORING AND ANALYTICS SOFTWARE
    • 6.3.1.1 Evolving need for continuous surveillance of organizational activities to aid growth
  • 6.3.2 GOVERNANCE, RISK, AND COMPLIANCE PLATFORMS
    • 6.3.2.1 Growing shift from reactive compliance management to proactive risk prevention to boost market
• 6.4 CLINICAL SAFETY CONTROLS
  • 6.4.1 MEDICATION SAFETY & PHARMACY-LEVEL CONTROL SOFTWARE
    • 6.4.1.1 Need to prevent medication errors to contribute to growth
  • 6.4.2 INFECTION CONTROL SYSTEMS
    • 6.4.2.1 Rise in proactive surveillance, rapid intervention, and continuous monitoring to expedite growth
• 6.5 FINANCIAL & LEGAL RISK HANDLING
  • 6.5.1 CLAIMS MANAGEMENT SOLUTIONS
    • 6.5.1.1 Need to leverage data-driven claims management to minimize costs to favor growth
  • 6.5.2 REVENUE INTEGRITY & RISK MANAGEMENT SOLUTIONS
    • 6.5.2.1 Growing focus on minimizing financial and legal risks to propel market

7 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY DEPLOYMENT MODE

• 7.1 INTRODUCTION
• 7.2 ON-PREMISE DEPLOYMENT
  • 7.2.1 HIGHER CONTROL, SECURITY, AND CUSTOMIZATION TO BOLSTER GROWTH
• 7.3 CLOUD-BASED DEPLOYMENT
  • 7.3.1 NEED TO REDUCE IT OVERHEAD AND ENABLE FASTER INNOVATION TO SPUR GROWTH
• 7.4 HYBRID DEPLOYMENT
  • 7.4.1 ABILITY TO SUPPORT REAL-TIME INCIDENT REPORTING, ROOT CAUSE ANALYSIS, AND COMPLIANCE MONITORING TO DRIVE MARKET

8 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY END USER

• 8.1 INTRODUCTION
• 8.2 HEALTHCARE PROVIDERS
  • 8.2.1 HOSPITALS
    • 8.2.1.1 Rising demand for high-quality care and patient safety to accelerate growth
  • 8.2.2 CLINICS
    • 8.2.2.1 Increasing demand for quality care in outpatient and ambulatory settings to facilitate growth
  • 8.2.3 AMBULATORY CARE CENTERS
    • 8.2.3.1 Growing shift toward outpatient and value-based care models to drive market
  • 8.2.4 LONG-TERM CARE CENTERS
    • 8.2.4.1 Increasing focus on elderly care and patients with chronic conditions to aid growth
  • 8.2.5 PHARMACIES
    • 8.2.5.1 Enhanced medical safety and regulatory compliance to augment growth
  • 8.2.6 OTHER HEALTHCARE PROVIDERS
• 8.3 PHARMACEUTICAL & BIOTECH COMPANIES
  • 8.3.1 NEED TO MAINTAIN PRODUCT QUALITY, REGULATORY COMPLIANCE, AND PHARMACOVIGILANCE TO ENCOURAGE GROWTH
• 8.4 HEALTHCARE PAYERS
  • 8.4.1 INCREASING ADOPTION OF PATIENT SAFETY AND RISK SOFTWARE FOR ENHANCED QUALITY ACROSS HEALTHCARE ECOSYSTEM TO AID GROWTH
• 8.5 MEDTECH COMPANIES
  • 8.5.1 GROWING RISK OF DATA INTEGRITY AND CYBERSECURITY TO FUEL MARKET
• 8.6 OTHER END USERS

9 PATIENT SAFETY AND RISK SOFTWARE MARKET, BY REGION

• 9.1 INTRODUCTION
• 9.2 NORTH AMERICA
  • 9.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA
  • 9.2.2 US
    • 9.2.2.1 Increasing initiatives for improving patient and healthcare workforce safety to aid growth
  • 9.2.3 CANADA
    • 9.2.3.1 Rise in patient safety improvement programs to contribute to growth
• 9.3 EUROPE
  • 9.3.1 MACROECONOMIC OUTLOOK FOR EUROPE
  • 9.3.2 GERMANY
    • 9.3.2.1 Targeted government policies and push toward modernizing healthcare delivery to propel market
  • 9.3.3 UK
    • 9.3.3.1 Growing initiatives on improving patient outcomes and reducing medical errors to drive market
  • 9.3.4 FRANCE
    • 9.3.4.1 Increasing use of integrated digital platforms in hospitals to expedite growth
  • 9.3.5 ITALY
    • 9.3.5.1 Favorable national legislation and regional healthcare policies to promote growth
  • 9.3.6 SPAIN
    • 9.3.6.1 Rising commitment toward enhanced healthcare quality and culture of safety to aid growth
  • 9.3.7 REST OF EUROPE
• 9.4 ASIA PACIFIC
  • 9.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC
  • 9.4.2 CHINA
    • 9.4.2.1 Increasing deployment of critical incident reporting systems and EHR-linked safety modules to fuel market
  • 9.4.3 JAPAN
    • 9.4.3.1 Growing focus on supporting error reporting, root cause analysis, and clinical protocols to boost market
  • 9.4.4 INDIA
    • 9.4.4.1 Strong public-private sector initiatives to support growth
  • 9.4.5 AUSTRALIA
    • 9.4.5.1 Increasing emphasis on quality improvement across public and private hospitals to spur growth
  • 9.4.6 SOUTH KOREA
    • 9.4.6.1 Innovation-driven healthcare ecosystem to facilitate growth
  • 9.4.7 REST OF ASIA PACIFIC
• 9.5 LATIN AMERICA
  • 9.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA
  • 9.5.2 BRAZIL
    • 9.5.2.1 Increasing focus on reducing adverse events and hospital-acquired infections to encourage growth
  • 9.5.3 MEXICO
    • 9.5.3.1 Expanding healthcare digitization and national policies promoting patient safety to drive market
  • 9.5.4 REST OF LATIN AMERICA
• 9.6 MIDDLE EAST & AFRICA
  • 9.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA
  • 9.6.2 GCC COUNTRIES
    • 9.6.2.1 Saudi Arabia
      • 9.6.2.1.1 Increasing modernization efforts in healthcare to accelerate growth
    • 9.6.2.2 UAE
      • 9.6.2.2.1 Evolving digital health landscape to favor growth
    • 9.6.2.3 Rest of GCC countries
  • 9.6.3 SOUTH AFRICA
    • 9.6.3.1 Increasing awareness about patient safety in public and private healthcare sectors to boost market
  • 9.6.4 REST OF MIDDLE EAST & AFRICA

10 COMPETITIVE LANDSCAPE

• 10.1 INTRODUCTION
• 10.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
  • 10.2.1 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN PATIENT SAFETY AND RISK SOFTWARE MARKET
• 10.3 REVENUE SHARE ANALYSIS, 2020-2024
• 10.4 MARKET SHARE ANALYSIS, 2024
• 10.5 BRAND/SOFTWARE COMPARISON
• 10.6 COMPANY VALUATION AND FINANCIAL METRICS
  • 10.6.1 COMPANY VALUATION
  • 10.6.2 FINANCIAL METRICS
• 10.7 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024
  • 10.7.1 STARS
  • 10.7.2 EMERGING LEADERS
  • 10.7.3 PERVASIVE PLAYERS
  • 10.7.4 PARTICIPANTS
  • 10.7.5 COMPANY FOOTPRINT, 2024
    • 10.7.5.1 Company footprint
    • 10.7.5.2 Region footprint
    • 10.7.5.3 Deployment mode footprint
    • 10.7.5.4 Function footprint
    • 10.7.5.5 End-user footprint
• 10.8 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2024
  • 10.8.1 PROGRESSIVE COMPANIES
  • 10.8.2 RESPONSIVE COMPANIES
  • 10.8.3 DYNAMIC COMPANIES
  • 10.8.4 STARTING BLOCKS
  • 10.8.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2024
    • 10.8.5.1 Detailed list of key startups/SMEs
    • 10.8.5.2 Competitive benchmarking of key startups/SMEs
• 10.9 COMPETITIVE SCENARIO
  • 10.9.1 SOLUTION LAUNCHES AND ENHANCEMENTS
  • 10.9.2 DEALS
  • 10.9.3 EXPANSIONS

11 COMPANY PROFILES

• 11.1 KEY PLAYERS
  • 11.1.1 RISKONNECT, INC.
    • 11.1.1.1 Business overview
    • 11.1.1.2 Solutions offered
    • 11.1.1.3 Recent developments
      • 11.1.1.3.1 Solution launches and enhancements
      • 11.1.1.3.2 Deals
    • 11.1.1.4 MnM view
      • 11.1.1.4.1 Right to win
      • 11.1.1.4.2 Strategic choices
      • 11.1.1.4.3 Weaknesses and competitive threats
  • 11.1.2 ORIGAMI RISK LLC
    • 11.1.2.1 Business overview
    • 11.1.2.2 Solutions offered
    • 11.1.2.3 Recent developments
      • 11.1.2.3.1 Solution launches and enhancements
    • 11.1.2.4 MnM view
      • 11.1.2.4.1 Right to win
      • 11.1.2.4.2 Strategic choices
      • 11.1.2.4.3 Weaknesses and competitive threats
  • 11.1.3 RLDATIX
    • 11.1.3.1 Business overview
    • 11.1.3.2 Solutions offered
    • 11.1.3.3 Recent developments
      • 11.1.3.3.1 Solution launches and enhancements
      • 11.1.3.3.2 Deals
      • 11.1.3.3.3 Expansions
    • 11.1.3.4 MnM view
      • 11.1.3.4.1 Right to win
      • 11.1.3.4.2 Strategic choices
      • 11.1.3.4.3 Weaknesses and competitive threats
  • 11.1.4 HEALTH CATALYST
    • 11.1.4.1 Business overview
    • 11.1.4.2 Solutions offered
    • 11.1.4.3 Recent developments
      • 11.1.4.3.1 Solution launches and enhancements
      • 11.1.4.3.2 Deals
  • 11.1.5 SYMPLR
    • 11.1.5.1 Business overview
    • 11.1.5.2 Solutions offered
    • 11.1.5.3 Recent developments
      • 11.1.5.3.1 Solution launches and enhancements
      • 11.1.5.3.2 Deals
    • 11.1.5.4 MnM view
      • 11.1.5.4.1 Right to win
      • 11.1.5.4.2 Strategic choices
      • 11.1.5.4.3 Weaknesses and competitive threats
  • 11.1.6 CLARITY GROUP, INC.
    • 11.1.6.1 Business overview
    • 11.1.6.2 Solutions offered
  • 11.1.7 PERFORMANCE HEALTH PARTNERS
    • 11.1.7.1 Business overview
    • 11.1.7.2 Solutions offered
    • 11.1.7.3 Recent developments
      • 11.1.7.3.1 Deals
  • 11.1.8 MORCARE
    • 11.1.8.1 Business overview
    • 11.1.8.2 Solutions offered
  • 11.1.9 RISKQUAL TECHNOLOGIES, INC.
    • 11.1.9.1 Business overview
    • 11.1.9.2 Solutions offered
  • 11.1.10 PRISTA CORPORATION
    • 11.1.10.1 Business overview
    • 11.1.10.2 Solutions offered
  • 11.1.11 SAFEQUAL
    • 11.1.11.1 Business overview
    • 11.1.11.2 Solutions offered
  • 11.1.12 IQVIA
    • 11.1.12.1 Business overview
    • 11.1.12.2 Solutions offered
    • 11.1.12.3 Recent developments
      • 11.1.12.3.1 Solution launches and enhancements
      • 11.1.12.3.2 Deals
  • 11.1.13 INOVALON
    • 11.1.13.1 Business overview
    • 11.1.13.2 Solutions offered
    • 11.1.13.3 Recent developments
      • 11.1.13.3.1 Solution launches and enhancements
  • 11.1.14 NAVEX GLOBAL, INC.
    • 11.1.14.1 Business overview
    • 11.1.14.2 Solutions offered
    • 11.1.14.3 Recent developments
      • 11.1.14.3.1 Solution launches and enhancements
      • 11.1.14.3.2 Deals
      • 11.1.14.3.3 Expansions
  • 11.1.15 CENSINET
    • 11.1.15.1 Business overview
    • 11.1.15.2 Solutions offered
    • 11.1.15.3 Recent developments
      • 11.1.15.3.1 Solution launches and enhancements
  • 11.1.16 AMERICAN DATA NETWORK
    • 11.1.16.1 Business overview
    • 11.1.16.2 Solutions offered
  • 11.1.17 ARVENTA
    • 11.1.17.1 Business overview
    • 11.1.17.2 Solutions offered
  • 11.1.18 COMPLIANCEQUEST
    • 11.1.18.1 Business overview
    • 11.1.18.2 Solutions offered
    • 11.1.18.3 Recent developments
      • 11.1.18.3.1 Solution launches and enhancements
      • 11.1.18.3.2 Deals
  • 11.1.19 RADAR HEALTHCARE INC
    • 11.1.19.1 Business overview
    • 11.1.19.2 Solutions offered
  • 11.1.20 PASCAL METRICS INC.
    • 11.1.20.1 Business overview
    • 11.1.20.2 Solutions offered
• 11.2 OTHER PLAYERS
  • 11.2.1 OMNIGO
  • 11.2.2 LOGICMANAGER, INC.
  • 11.2.3 DEXUR
  • 11.2.4 HEALTHCARE GRC PTE LTD.
  • 11.2.5 NOSOTECH INC.

12 APPENDIX

• 12.1 DISCUSSION GUIDE
• 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
• 12.3 CUSTOMIZATION OPTIONS
• 12.4 RELATED REPORTS
• 12.5 AUTHOR DETAILS